Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Michael E. Thase(The University of Texas at San Antonio Health Science Center), Edward S. Friedman(University of Pittsburgh), L. Gyulai(University of Pennsylvania), Joseph R. Calabrese(University Hospitals of Cleveland), Andrew A. Nierenberg(Andrews University), Terence A. Ketter(Universidade Federal do Rio Grande do Sul), Lauren B. Marangell(Baylor College of Medicine), Stephen R. Wisniewski, Michael W. Otto(Harvard University), Michael J. Ostacher(VA Palo Alto Health Care System), Péter Hauser(Portland VA Medical Center), David J. Miklowitz, Jayendra K. Patel(University of Massachusetts Chan Medical School), James M. Martinez(Baylor College of Medicine), Charles L. Bowden(The University of Texas at San Antonio Health Science Center), Ellen B. Dennehy(Eli Lilly (United States)), Daniel Rapport(University of Toledo), Mark D. Fossey(University of Oklahoma), Michael H. Allen
Cited by 925
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754